| abstract |
The invention relates to a pharmaceutical composition for the treatment of a solid tumor selected from the group consisting of colon cancer, gastric tumor, mammary tumor, ovarian tumor, prostate tumor and kidney tumor, which composition contains sodium meta-arsenite (NaAsO2) and a pharmaceutically acceptable adjuvant. The invention also relates to the use of sodium meta arsenite (NaAsO2) and a pharmaceutically acceptable adjuvant for the treatment of a solid tumor selected from the group consisting of colon cancer, gastric tumor, mammary tumor, ovarian tumor, prostate tumor and kidney tumor. |